Related Experiment Video
Updated: May 20, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Identification & Characterization of lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics
Faraz Shaikh1, Pa Abhinand, Pk Ragunath
1Department of Bioinformatics, Sri Ramachandra University, Porur, Chennai - 600 116, India.
Unlabelled:
Therapeutic agents with a goal to eradicate cancer needs to capable of inhibiting the growth and kill, any preformed tumor and should also inhibit oncogenic transformation of normal cells to cancer cells. Bacteriocins are bacterial proteins produced to prevent the growth of competing microorganisms in a particular biological niche and have been proved to possess antineoplastic activity. The entire genome of Lactobacillus salavarius was scanned for putative bacteriocins and subsequently these bacteriocins were characterized by subjecting them as functional annotation algorithms. Azurin is a well characterized bacteriocins with proven cytostatic and apoptotic effect against human cancer cell and was taken as control. Functional characterization revealed that the three bacteriocins Lsl_003, Lsl_0510, Lsl_0554 possessed functional properties very similar to that of Azurin. Molecular screening of these bacteriocins against the common cancer targets p53, Rb1 and AR revealed that Lsl_0510 possessed highest binding affinity towards the all the three receptors making it to ideal candidate for future cancer therapeutics.
Abbreviations:
P53 - Protein 53, Rb1 - Retinoblastoma 1, AR - Androgen Receptor, Lsl - Lactobacillus salavarius.
Insights
Researchers identified novel bacteriocins from Lactobacillus salavarius with potential anticancer properties. One bacteriocin, Lsl_0510, showed significant binding affinity to key cancer targets, indicating promise for new cancer therapeutics.
Area of Science:
- Microbiology
- Biochemistry
- Cancer Research
Background:
- Bacteriocins, antimicrobial peptides from bacteria, exhibit potential antineoplastic activities.
- Lactobacillus salavarius (Lsl) genome was screened for novel bacteriocins.
- Azurin, a known bacteriocin with cytostatic and apoptotic effects, served as a control.
Purpose of the Study:
- To identify and characterize bacteriocins from Lactobacillus salavarius with potential anticancer properties.
- To evaluate the functional similarity of identified bacteriocins to Azurin.
- To assess the binding affinity of bacteriocins to cancer-related targets: p53, Retinoblastoma 1 (Rb1), and Androgen Receptor (AR).
Main Methods:
- Genome-wide scanning of Lactobacillus salavarius for putative bacteriocins.
- Functional annotation and characterization of identified bacteriocins.
- Molecular screening and binding affinity assays against p53, Rb1, and AR.
Main Results:
- Three bacteriocins (Lsl_003, Lsl_0510, Lsl_0554) were identified and functionally characterized.
- These bacteriocins demonstrated functional properties similar to Azurin.
- Lsl_0510 exhibited the highest binding affinity to p53, Rb1, and AR.
Conclusions:
- Lactobacillus salavarius harbors bacteriocins with promising anticancer potential.
- Lsl_0510 is a strong candidate for developing novel cancer therapeutics due to its high binding affinity to key cancer targets.
- Further research into Lsl_0510 could lead to new strategies for cancer treatment.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
lncRNA - Long Non-coding RNAs
Selectins
Biological Methods for Microbial Control
